MAYANA ZATZ

Prof. Dr. MAYANA ZATZ


Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2004 in The American Journal of Human Genetics
Verified
Journal Article
Closed access
ANAgnes L. Nishimura
Agnes L. Nishimura
MMMiguel Mitne-Neto
Miguel Mitne-Neto
HSHelga C.A. Silva
Helga C.A. Silva
ARAntônio Richieri-Costa
Antônio Richieri-Costa
SMSusan Middleton
Susan Middleton
MZMAYANA ZATZ
MAYANA ZATZ

11 October 2007 in Stem Cells
Verified
Journal Article
Closed access
PDF file
MSMariane Secco
Mariane Secco
EZEder Zucconi
Eder Zucconi
NVNatassia M. Vieira
Natassia M. Vieira
LFLuciana L.Q. Fogaça
Luciana L.Q. Fogaça
ACAntonia Cerqueira
Antonia Cerqueira
MZMAYANA ZATZ
MAYANA ZATZ
The identification of mesenchymal stem cell (MSC) sources that are easily obtainable is of utmost importance. Several studies have shown that MSCs could be isolated from umbilical cord (UC) units. However, the presence of MSCs in umbilical cord blood (UCB) is controversial. A possible explanation for the low efficiency of MSCs from UCB is the use of different culture conditions by independent studies. Here, we compared the efficiency in obtaining MSCs from unrelated paired UCB and UC samples harvested from the same donors. Samples were processed simultaneously, under the same culture conditions. Although MSCs from blood were obtained from only 1 of the 10 samples, we were able to isolate large amounts of multipotent MSCs from all UC samples, which were able to originate different cell lineages. Since the routine procedure in UC banks has been to store the blood and discard other tissues, such as the cord and/or placenta, we believe our results are of immediate clinical value. Furthermore, the possibility of originating different cell lines from the UC of neonates born with genetic defects may provide new cellular research models for understanding human malformations and genetic disorders, as well as the possibility of testing the effects of different therapeutic drugs. Disclosure of potential conflicts of interest is found at the end of this article.

23 March 2017 in Human Mutation
Verified
Journal Article
Closed access
PDF file
MNMichel Satya Naslavsky
Michel Satya Naslavsky
GYGuilherme Lopes Yamamoto
Guilherme Lopes Yamamoto
TATatiana Ferreira Almeida
Tatiana Ferreira Almeida
SESuzana A. M. Ezquina
Suzana A. M. Ezquina
DSDaniele Yumi Sunaga-Franze
Daniele Yumi Sunaga-Franze
MZMAYANA ZATZ
MAYANA ZATZ

9 June 2005 in New England Journal of Medicine
Verified
Journal Article
Closed access
MZMAYANA ZATZ
MAYANA ZATZ
ASAlessandra Starling
Alessandra Starling
Calpains are members of a large family of Ca2+-dependent proteolytic enzymes. Some are tissue-specific; others are ubiquitous. Poised to digest numerous intracellular proteins, their potential to cause or contribute to disease is considerable. This review outlines the structure and function of calpains and their involvement in a type of muscular dystrophy, type 2 diabetes, cataracts, and Alzheimer's disease.

17 June 2011 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
MMMiguel Mitne-Neto
Miguel Mitne-Neto
MMMarcela Machado-Costa
Marcela Machado-Costa
MMMaria C.N. Marchetto
Maria C.N. Marchetto
MBMario H. Bengtson
Mario H. Bengtson
CJClaudio A. Joazeiro
Claudio A. Joazeiro
MZMAYANA ZATZ
MAYANA ZATZ
Amyotrophic lateral sclerosis (ALS) is an incurable neuromuscular disease that leads to a profound loss of life quality and premature death. Around 10% of the cases are inherited and ALS8 is an autosomal dominant form of familial ALS caused by mutations in the vamp-associated protein B/C (VAPB) gene. The VAPB protein is involved in many cellular processes and it likely contributes to the pathogenesis of other forms of ALS besides ALS8. A number of successful drug tests in ALS animal models could not be translated to humans underscoring the need for novel approaches. The induced pluripotent stem cells (iPSC) technology brings new hope, since it can be used to model and investigate diseases in vitro. Here we present an additional tool to study ALS based on ALS8-iPSC. Fibroblasts from ALS8 patients and their non-carrier siblings were successfully reprogrammed to a pluripotent state and differentiated into motor neurons. We show for the first time that VAPB protein levels are reduced in ALS8-derived motor neurons but, in contrast to over-expression systems, cytoplasmic aggregates could not be identified. Our results suggest that optimal levels of VAPB may play a central role in the pathogenesis of ALS8, in agreement with the observed reduction of VAPB in sporadic ALS.

22 July 2008 in Lasers in Surgery and Medicine
Verified
Journal Article
Closed access
PDF file
FEFernanda de P. Eduardo
Fernanda de P. Eduardo
Daniela Franco BuenoDaniela Franco Bueno
Daniela Franco Bueno
PFPatricia M. de Freitas
Patricia M. de Freitas
MMMarques Martins Marques
Marques Martins Marques
MPMaria Rita Passos‐Bueno
Maria Rita Passos‐Bueno
MZMAYANA ZATZ
MAYANA ZATZ